Literature DB >> 11472876

The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in dopaminergric neurons of mesencephalic cultures.

T Gearan1, O A Castillo, M A Schwarzschild.   

Abstract

The stress-activated protein kinase (SAPK) cascade serves a critical role in the apoptotic death of neuronal cells in response to a variety of cellular stresses. Recent in vitro and in vivo evidence has directly implicated this kinase in the death of dopaminergic nigral neurons in the MPTP model of Parkinson's disease (PD). To assess the involvement of c-Jun, a key transcription factor substrate of SAPK (also known as c-Jun N-terminal kinase, or JNK) in the MPTP-induced death of dopaminergic nigral neurons, we determined the ability of MPP+, the active toxin metabolite of MPTP, to induce the phosphorylated form of c-Jun in dopaminergic neurons in nigral (ventral mesencephalon) cultures. At a dose of MPP+ that specifically induces apoptotic changes in nuclear morphology in tyrosine hydroxylase-positive (dopaminergic) cells in these cultures, MPP+ induces nuclear phospho-c-Jun immunoreactivity (IR). The peak induction of phospho-c-Jun IR was observed 16h after beginning MPP+ exposure, and preceded the maximal induction of apoptotic nuclear changes by approximately 8h. These data support an important role for the SAPK/JNK pathway including its c-Jun transcriptional target in the apoptotic death of dopaminergic nigral neurons in the MPTP model of PD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472876     DOI: 10.1016/s1353-8020(00)00078-x

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray.

Authors:  Silvia Mandel; Edna Grünblatt; Gila Maor; Moussa B H Youdim
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway.

Authors:  Margarida Castro-Caldas; Andreia Neves Carvalho; Elsa Rodrigues; Colin Henderson; C Roland Wolf; Maria João Gama
Journal:  Mol Neurobiol       Date:  2012-04-27       Impact factor: 5.590

3.  Small Molecule c-jun-N-terminal Kinase (JNK) Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's Disease.

Authors:  Jeremy W Chambers; Alok Pachori; Shannon Howard; Michelle Ganno; Donald Hansen; Ted Kamenecka; Xinyi Song; Derek Duckett; Weimin Chen; Yuan Yuan Ling; Lisa Cherry; Michael D Cameron; Li Lin; Claudia H Ruiz; Philip Lograsso
Journal:  ACS Chem Neurosci       Date:  2011-04-20       Impact factor: 4.418

4.  The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease.

Authors:  Pascaline Aimé; Saravanan S Karuppagounder; Apeksha Rao; Yingxin Chen; Robert E Burke; Rajiv R Ratan; Lloyd A Greene
Journal:  Neurobiol Dis       Date:  2020-01-03       Impact factor: 5.996

5.  Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.

Authors:  Pascaline Aimé; Xiaotian Sun; Neela Zareen; Apeksha Rao; Zachary Berman; Laura Volpicelli-Daley; Paulette Bernd; John F Crary; Oren A Levy; Lloyd A Greene
Journal:  J Neurosci       Date:  2015-07-29       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.